[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100641202":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":46,"collaborators":10,"id":48,"slug":10,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":49,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":61,"studyType":62,"phases":10,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":75,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Cortex Neurovascular","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Migraine Patients Undergoing MMA Embolization",null,"Adults aged 18 to 64 years with a diagnosis of migraine who have undergone or plan to undergo middle meningeal artery (MMA) embolization as part of routine clinical care. Participants are enrolled in an observational registry that accesses and analyzes clinical and patient-reported outcome data already documented through routine care. Study participation does not influence clinical management, procedural technique, device selection, or follow-up.",[13],"Procedure: Middle Meningeal Artery Embolization",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"PROCEDURE","Middle Meningeal Artery Embolization","Middle meningeal artery (MMA) embolization performed as part of routine clinical care at the discretion of the treating physician. The procedure is independent of study participation and is not assigned by the study protocol. The research activity consists solely of accessing and analyzing data already documented through routine clinical care.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Dennis Wang, Principal Investigator, MD","CONTACT","253-284-0841","dwang@cortexmgmt.com",[27],{"facility":28,"status":10,"city":29,"state":30,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Cortex Neurovascular \u002F TRA Union","Tacoma","Washington","98405","United States",{"type":34,"coordinates":35},"Point",[36,37],-122.44429,47.25288,{"lat":37,"lon":36},[40,42,43],{"name":41,"role":23,"phone":24,"phoneExt":10,"email":25},"Dennis Wang, MD",{"name":10,"role":23,"phone":10,"phoneExt":10,"email":25},{"name":44,"role":45,"phone":10,"phoneExt":10,"email":10},"Dennis O Wang, MD","PRINCIPAL_INVESTIGATOR",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100641202",false,"NCT07652034","EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine","Enduring Migraine Benefit From Responsive Artery Coil Embolization - Observational (EMBRACE-OBS): A Single-Site Registry of Patient-Reported Outcomes Following Routine Clinical Care for Migraine","EMBRACE-OBS","Inclusion Criteria:\n\n* Adults aged 18 to 64 years\n* Diagnosis of migraine\n* Have undergone or plan to undergo middle meningeal artery (MMA) embolization as part of routine clinical care, independent of study participation\n* Able and willing to provide informed consent\n* Able to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments\n\nExclusion Criteria:\n\n* Age under 18 years\n* Pregnancy at the time of enrollment\n* Inability to provide informed consent\n* Inability to read and understand English sufficiently to complete informed consent and patient-reported outcome assessments\n* Insufficient clinical or patient-reported outcome data for the planned analyses","ALL","18 Years","64 Years",{"count":59,"type":60},50,"ESTIMATED","12 Months","OBSERVATIONAL","EMBRACE-OBS is the first phase of the EMBRACE research program. This single-site observational registry accesses and analyzes patient-reported outcome data already collected through routine clinical care from adults with migraine who have undergone or plan to undergo middle meningeal artery (MMA) embolization. The study describes changes in headache frequency, headache severity, medication use, migraine-related disability, quality of life, and reported adverse events over time without influencing clinical care.",[65,66,67],"Migraine Disorders","Chronic Migraine Headache","Migraine",[17,69,67,70,71,72,73,74,53],"MMA Embolization","Headache","Patient-Reported Outcomes","HIT-6","Observational Registry","Neurointervention","NOT_YET_RECRUITING","2026-06-16",{"date":78,"type":79},"2026-06-18","ACTUAL",{"date":81,"type":60},"2026-07-01",{"date":83,"type":60},"2028-06-01",{"name":5,"class":6},1]